Clinical trial
Comparison of Different Combination Chemotherapy Regimens in Treating Children…
NCT00005945 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005945 |
|---|---|
| Title | Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia |
| Official title | Escalating Dose Intravenous Methotrexate Without Leucovorin Rescue Versus Oral Methotrexate and Single Versus Double Delayed Intensification for Children With Standard Risk Acute Lymphoblastic Leukemia |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, mercaptopurine, methotrexate, pegaspargase, thioguanine, vincristine sulfate and 1 more |
| Enrollment | 3,054 |
| Start date | Jun 1, 2000 |
| Primary completion | Nov 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 23, 2016 |
| Countries | Australia, Canada, New Zealand, Switzerland, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: